510(k) Report

510(k) · Cleared

Cleared

XLR8 Plus (XLR8+)

K141437510(k) SpecialCleared Sep 19, 2014112-day reviewClass II21 CFR 878.4780

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Genadyne Biotechnologies, Inc. · OMP Negative Pressure Wound Therapy Powered Suction Pump

Cleared on Sep 19, 2014 as substantially equivalent to K090638 (Genadyne Biotechnologies, Inc., 2009) after a 112-day review. Its family tree reaches back 6 generations to 1995.

Decided
Sep 19, 2014
Review
112 days
Class
Class II
Product code
OMP
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K945062 (1995). 7 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 6 generations backK945062 VacplusKinetic Concepts, Inc. · 1995
  2. 5 generations backK042134 Versatile 1 Wound Vacuum SystemBlue Sky Medical Group Incorporated · 2004 · Recalled
  3. 4 generations backK052456 Modification to Versatile 1 Wound Vacuum SystemBlue Sky Medical Group Incorporated · 2005
  4. 3 generations backK061367 Bluesky Vista Wound Vacuum System, Model 100.0500Blue Sky Medical Group Incorporated · 2006
  5. 2 generations backK082676 Genadyne A4 Wound Vacuum SystemGenadyne Biotechnologies, Inc. · 2008
  6. 1 generation backK090638 Genadyne A4-XLR8 Wound Vacuum SystemGenadyne Biotechnologies, Inc. · 2009
  7. This deviceK141437 XLR8 Plus (XLR8+)Genadyne Biotechnologies, Inc. · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K945062VacplusKinetic Concepts, Inc.1995—
−5K042134Versatile 1 Wound Vacuum SystemBlue Sky Medical Group Incorporated20042
−4K052456Modification to Versatile 1 Wound Vacuum SystemBlue Sky Medical Group Incorporated2005—
−3K061367Bluesky Vista Wound Vacuum System, Model 100.0500Blue Sky Medical Group Incorporated2006—
−2K082676Genadyne A4 Wound Vacuum SystemGenadyne Biotechnologies, Inc.2008—
−1K090638Genadyne A4-XLR8 Wound Vacuum SystemGenadyne Biotechnologies, Inc.2009—
0 (this device)K141437XLR8 Plus (XLR8+)Genadyne Biotechnologies, Inc.2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
FIG. 1 — Lineage of K141437, 1995–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OMP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OMP device

  1. #1 K260646 Renasys Edge (66803126)score 15.3 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K090638Genadyne A4-XLR8 Wound Vacuum System
Summary page 4
…y 10. Reason for Premarket New Device Notification 11. Identification of Legally A4-XLR8 Wound Vacuum System Marketed Device Which We K090638 Can Claim Substantial Equivalence (Predicate Device) 12. Brief Description of Device The XLR8 Plus (XLR8+)…
Genadyne Biotechnologies, Inc.2009—

Also cleared against K090638: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 3 companies; a new generation was cleared every 2.4 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • 1 other device also cites its predicate K090638.

How does its category compare?

All OMP devices

OMP Negative Pressure Wound Therapy Powered Suction Pump: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · OMP

5in 2025

2007: 62008: 82009: 82010: 62011: 62012: 112013: 112014: 102015: 202016: 192017: 112018: 132019: 152020: 62021: 92022: 102023: 82024: 92025: 52026 (partial year): 9
2007high 20 (2015) · low 5 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OMP

127in 2025

2007: 113 days median2008: 98 days median2009: 87 days median2010: 97 days median2011: 123 days median2012: 292 days median2013: 84 days median2014: 179 days median2015: 189 days median2016: 146 days median2017: 137 days median2018: 214 days median2019: 249 days median2020: 179 days median2021: 238 days median2022: 229 days median2023: 291 days median2024: 181 days median2025: 127 days median2026 (partial year): 141 days median
2007high 292 (2012) · low 84 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OMP

2in 2024

2009: 72010: 32012: 12013: 22014: 42015: 12016: 22019: 12024: 2
2007high 7 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OMP

140in 2025

2007: 12008: 12009: 792010: 802011: 1302012: 972013: 1692014: 2292015: 3782016: 3982017: 3682018: 4222019: 9942020: 3,6642021: 1,4222022: 2582023: 1432024: 1352025: 140
2007high 3,664 (2020) · low 1 (2007)2025

MAUDE reports naming product code OMP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007611301
200889801
2009887779
2010697380
201161230130
201211292197
201311842169
2014101794229
2015201891378
2016191462398
2017111370368
2018132140422
2019152491994
2020617903,664
2021923801,422
2022102290258
202382910143
202491812135
202551270140
202691410—

What is it indicated for?

The XLR8 Plus (XLR8+) Wound Vacuum System is indicated for use in patients who would benefit from negative pressure wound therapy particularly as the device may promote wound healing by the removal of excess exudates, infectious material and tissue debris.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K141437: XLR8 Plus (XLR8+).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K141437

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026